微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 54.3% | 4.53% | -2.99% | 69/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 55.97% | 9.76% | 6.5% | 64/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 52.55% | -0.73% | 0.81% | 69/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 52.13% | -1.49% | 0.36% | 71/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 51.94% | -1.39% | 1.86% | 73/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 51% | -1.05% | -3.67% | 69/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 52.94% | 7.74% | 0.04% | 71/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 52.92% | 33.69% | 0.46% | 70/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 52.68% | 8.11% | 2.21% | 72/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 51.54% | 2% | 4.89% | 69/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 49.14% | 8.23% | 0.84% | 80/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 48.72% | 11.61% | 7.32% | 77/141 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2022-12-31 | 45.4% | 19.05% | 4% | 86/141 | 54.01% | 正海生物 | 90.3% | 行业排名> |
| 2022-06-30 | 43.66% | 2% | 14.47% | 86/141 | 55.37% | 万泰生物 | 91.61% | 行业排名> |
| 2021-12-31 | 38.14% | -10.98% | -3.65% | 109/141 | 57.98% | 三友医疗 | 90.18% | 行业排名> |
| 2021-09-30 | 39.58% | 2% | -7.6% | 90/141 | 59.77% | 三友医疗 | 90.14% | 行业排名> |
| 2020-12-31 | 42.84% | 2% | 2% | 105/141 | 60.12% | 三友医疗 | 90.29% | 行业排名> |